Suchergebnisse - "Su, Yingying"

PubPharm (448)

31

Advances in Cas12a-Based Amplification-Free Nucleic Acid Detection

enthalten in: The CRISPR journal | 2023

von Ji, S. | Wang, X. | Wang, Y. | +4

32

Hydrogen Sulfide Attenuates Mesenchymal Stem Cell Aging Progress via the Calcineurin-NFAT Signaling Pathway

enthalten in: Stem cells (Dayton, Ohio) | 2023

von Yang, S. | Su, Y. | Li, X. | +8

33

The neuroprotective role of prolonged normobaric oxygenation applied during ischemia and in the early stage of reperfusion in cerebral ischemic rats

enthalten in: Brain research | 2023

von Gao, D. | Yuan, S. | Ji, X. | +2

34

Quantitative EEG and brain network analysis : predicting awakening from early coma after cardiopulmonary resuscitation

enthalten in: Neurological research | 2023

von Jiang, M. | Niu, Z. | Liu, G. | +3

35

Taxifolin Inhibits the Growth of Non-Small-Cell Lung Cancer via Downregulating Genes Displaying Novel and Robust Associations with Immune Evasion Factors

enthalten in: Cancers | 2023

von Lin, X. | Dong, Y. | Gu, Y. | +8

36

The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China : a long-term community surveillance study

enthalten in: BMC public health | 2023

von Qiu, L. | Liu, S. | Zhang, M. | +18

37

The epidemiology of varicella and effectiveness of varicella vaccine in Ganyu, China: a long-term community surveillance study

enthalten in: BMC public health | 2023

von Qiu, L. | Liu, S. | Zhang, M. | +18

38

The role of vesicle trafficking genes in osteoblast differentiation and function

enthalten in: Scientific reports | 2023

von Zhu, H. | Su, Y. | Wang, J. | +1

39

Reconsideration of maternal serological testing for predicting congenital CMV infection

enthalten in: The Journal of infectious diseases | 2023

von Huang, Y. | Tang, J. | Yu, H. | +16

40

Long-term follow-up of phenobarbital versus valproate for generalized convulsive status epilepticus in adults : A randomized clinical trial

enthalten in: Epilepsy research | 2023

von Liu, G. | Wang, Y. | Tian, F. | +5